StocksDeepDive
Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

MPLT — MapLight Therapeutics, Inc.

N/A · Quality 9/100

Value Score 30 days ago: 16.4 → today 12.7

Price
7.48
Intrinsic value
-
no positive per-share earnings - the P/E-blend method needs a profit to value
Margin of safety
-
Implied growth (reverse DCF)
-
a described calculation from stated inputs, not a forecast
Value Score
12.7
Quality
9
Psychology
34.9
Discovery
17.6
price/volume attention only
Moat score
n/a
erosion: none

Value Score: bottom 28% of Russell 3000 · Quality: bottom 7%

Open the interactive Deep Dive for MPLT →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/MPLT - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

What is MapLight Therapeutics, Inc.'s Value Score?

MapLight Therapeutics, Inc.'s Value Score is 12.7 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number. This is a described calculation from public data, not a recommendation.